EUR-Lex & EU Commission AI-Powered Semantic Search Engine
Modern Legal
- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Sign up for free to view them and see the most relevant paragraphs highlighted.
Case C-41/21 P: Appeal brought on 26 January 2021 by Allergan Holdings France against the judgment of the General Court (Third Chamber) delivered on 18 November 2020 in Case T-664/19, Allergan Holdings France v EUIPO — Dermavita (JUVEDERM ULTRA)
ECLI:EU:UNKNOWN:62021CN0041
62021CN0041
January 26, 2021
With Google you find a lot.
With us you find everything. Try it now!
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
14.6.2021
Official Journal of the European Union
C 228/13
(Case C-41/21 P)
(2021/C 228/17)
Language of the case: English
Parties
Appellant: Allergan Holdings France (represented by: T. de Haan, avocat, and J. Day, Solicitor)
Other parties to the proceedings: European Union Intellectual Property Office (EUIPO), Dermavita Co. Ltd
By order of 29 April 2021, the Court of Justice (Chamber determining whether appeals may proceed) held that the appeal was not allowed to proceed and that Allergan Holdings France should bear its own costs.
EurLex Case Law
AI-Powered Case Law Search
Query in any language with multilingual search
Access EUR-Lex and EU Commission case law
See relevant paragraphs highlighted instantly
Get Instant Answers to Your Legal Questions
Cancel your subscription anytime, no questions asked.Start 14-Day Free TrialAt Modern Legal, we’re building the world’s best search engine for legal professionals. Access EU and global case law with AI-powered precision, saving you time and delivering relevant insights instantly.